Loading
Lakewood-Amedex Inc., an east Manatee County-based clinical stage biopharmaceutical company that develops anti-bacterial compounds to treat serious infectious diseases and conditions, has replaced its longtime CEO with board chairman Peter Corr.
Corr, who was senior vice president for science and technology and head of worldwide pharmaceutical research and development at Pfizer until his 2006 retirement, has been chair of Lakewood-Amedex since 2020, according to a statement. He’s now executive chairman of Lakewood-Amedex, the company says, where he “will assume the strategic responsibilities of former CEO Steve Parkinson who left the company at the request of the board.”
Parkinson had been president and CEO Lakewood-Amedex, founded in 2006, since 2007, according to his LinkedIn profile. The company has been awarded 74 patents since its founding, according to tech company database crunchbase, with 13 pending patents. It’s raised $29.6 million, including $24 million in 2021, crunchbase reports.
Subscribe today. Cancel anytime.
Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.
